Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Chi Leung Chiang"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThe predictive value of programmed death-ligand 1 (PD-L1) expression in nasopharyngeal cancer (NPC) patients receiving immune checkpoint inhibitors (ICIs) remains controversial. This study aimed to evaluate the optimal threshold of PD-L1 ex
Externí odkaz:
https://doaj.org/article/6d026eab51364b7585d183e486f5bf1f
Autor:
Chi Leung Chiang, Qiaojuan Guo, Wai Tong Ng, Shaojun Lin, Tiffany Sze Wai Ma, Zhiyuan Xu, Youping Xiao, Jishi Li, Tianzhu Lu, Horace Cheuk Wai Choi, Wenqi Chen, Eric Sze Chun Chau, Peter Ho Yin Luk, Shao Hui Huang, Brian O’Sullivan, Jianji Pan, Anne Wing Mui Lee
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
This study aims to identify prognostic factors in nasopharyngeal carcinoma (NPC) to improve the current 8th edition TNM classification. A systematic review of the literature reported between 2013 and 2019 in PubMed, Embase, and Scopus was conducted.
Externí odkaz:
https://doaj.org/article/a2dc0f85e37847b69dd9b81b2d771a92
Autor:
Shing Fung Lee, Horace C. W. Choi, Sik Kwan Chan, Ka On Lam, Victor H. F. Lee, Irene O. L. Wong, Chi Leung Chiang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
ObjectivesWe aimed to compare the economic value of chemotherapy plus anti-epidermal growth factor receptor (anti-EGFR) monoclonal antibody (mAb) against chemotherapy with bevacizumab (Bev, an anti-vascular endothelial growth factor mAb) as first-lin
Externí odkaz:
https://doaj.org/article/111ed691c06345b4aa7a33edb674f9fd
Autor:
Chi-Leung Chiang, Keith Wan-Hang Chiu, Francis Ann-Shing Lee, Feng-Ming Spring Kong, Albert Chi-Yan Chan
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
Immunotherapy has achieved modest clinical activity in HCC patients. Propensity score matching analysis was conducted to compare the efficacy and safety of combined stereotactic SBRT-IO versus TACE in patients with locally advanced HCC in a tertiary
Autor:
Tianzhu Lu, Eric Sze Chun Chau, Anne Wing Mui Lee, Jianji Pan, Wenqi Chen, Qiaojuan Guo, Peter Ho Yin Luk, Youping Xiao, Shao Hui Huang, Shaojun Lin, Brian O'Sullivan, Chi-Leung Chiang, Wai Tong Ng, Zhiyuan Xu, Jishi Li, Tiffany Sze Wai Ma, Horace Cheuk Wai Choi
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
This study aims to identify prognostic factors in nasopharyngeal carcinoma (NPC) to improve the current 8th edition TNM classification. A systematic review of the literature reported between 2013 and 2019 in PubMed, Embase, and Scopus was conducted.
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncology
Frontiers in Oncology
Background: Current treatments of unresectable hepatocellular carcinoma (HCC) are trans-arterial chemo-embolization (TACE), stereotactic body radiotherapy (SBRT), and targeted therapy. However, these treatments are limited in efficacy and safety for
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: Current treatments of unresectable hepatocellular carcinoma (HCC) are trans-arterial chemo-embolization (TACE), stereotactic body radiotherapy (SBRT), and targeted therapy. However, these treatments are limited in efficacy and safety for
Externí odkaz:
https://doaj.org/article/b391c93337ac493686b5b7a93c3da069